Qlife Holding AB

ST:QLIFE Sweden Medical Devices
Market Cap
$2.82 Million
Skr31.67 Million SEK
Market Cap Rank
#33292 Global
#518 in Sweden
Share Price
Skr2.02
Change (1 day)
+0.50%
52-Week Range
Skr1.26 - Skr5.00
All Time High
Skr16052.19
Categories
Companies in Sweden Medical Devices
About

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vit… Read more

Qlife Holding AB - Asset Resilience Ratio

Latest as of March 2023: 15.26%

Qlife Holding AB (QLIFE) has an Asset Resilience Ratio of 15.26% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
Skr29.09 Million
Cash + Short-term Investments
Total Assets
Skr190.64 Million
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Qlife Holding AB's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Qlife Holding AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr0.00 0%
Short-term Investments Skr29.09 Million 15.26%
Total Liquid Assets Skr29.09 Million 15.26%

Asset Resilience Insights

  • Good Liquidity Position: Qlife Holding AB maintains a healthy 15.26% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Qlife Holding AB Industry Peers by Asset Resilience Ratio

Compare Qlife Holding AB's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 		Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 		Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901 		Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 		Medical Devices 6.64%
Shinhung
KO:004080 		Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256 		Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220 		Medical Devices 9.34%
HansBiomed Corporation
KQ:042520 		Medical Devices 9.13%

Annual Asset Resilience Ratio for Qlife Holding AB (None–None)

The table below shows the annual Asset Resilience Ratio data for Qlife Holding AB.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points